Sanofi
SNY
517 hedge funds and large institutions have $12.9B invested in Sanofi in 2015 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 200 increasing their positions, 161 reducing their positions, and 40 closing their positions.
156% more call options, than puts
Call options by funds: $40.3M | Put options by funds: $15.8M
68% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 40
30% more funds holding in top 10
Funds holding in top 10: 10 → 13 (+3)
24% more repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 161
12% more capital invested
Capital invested by funds: $11.6B → $12.9B (+$1.37B)
4% more funds holding
Funds holding: 498 → 517 (+19)
0.58% more ownership
Funds ownership: 19.06% → 19.64% (+0.58%)
Top Buyers
Top Sellers
SNY Hedge Fund Activity: Q1 2015 in Review
517 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2015, worth a combined $12.9B — up 12% from $11.6B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new SNY positions and 40 closed out — a net gain of 27 holders — while 200 added to existing stakes and 161 trimmed.
The largest buyer was Franklin Resources, adding an estimated $192M. The largest seller was Manning & Napier Advisors, cutting an estimated $140M.
- 517 institutional investors held Sanofi (SNY) as of Q1 2015, up from 498 in Q4 2014.
- Funds reported $12.9B of Sanofi stock for Q1 2015, up 12% quarter-over-quarter.
- 67 funds opened new Sanofi positions in Q1 2015 and 40 closed out, a net change of +27 holders.
- The largest Sanofi buyer in Q1 2015 was Franklin Resources, an estimated $192M added.
- The largest Sanofi seller in Q1 2015 was Manning & Napier Advisors, an estimated $140M sold.
Based on aggregated 13F filings for Q1 2015.